SCHEMBL7604098

SCHEMBL7604098

CC1(C)C(/C=C/C2=C(Cl)/C(=C/C=C3/N(CCO)c4ccccc4C3(C)C)CC2)=[N+](CCO)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 6/20 0.49
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
USP2 O75604 1/20 0.46
S1PR2 O95136 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
ALPG P10696 1/20 0.46
THRB P10828 1/20 0.46
PKM P14618 1/20 0.46
XBP1 P17861 1/20 0.46
CRHBP P24387 1/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
RAB9A P51151 1/20 0.46
BLM P54132 1/20 0.46
KMT2A Q03164 1/20 0.46
CRHR2 Q13324 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2587725 0.96 PRMT1 (0.48) PRMT1MAPTMEN1NPC1USP2
SCHEMBL10066306 0.96 PRMT1 (0.48) PRMT1MAPTMEN1NPC1USP2
Perchlorate SCHEMBL343336 0.94 MEN1 (0.49) PRMT1MAPTMEN1NPC1USP2
SCHEMBL12932098 0.89 PRMT1 (0.49) PRMT1MAPTMEN1NPC1USP2
SCHEMBL12020885 0.88 PRMT1 (0.53) PRMT1MAPTMEN1NPC1USP2
SCHEMBL16609257 0.88 PRMT1 (0.54) PRMT1MAPTMEN1NPC1USP2
SCHEMBL12713687 0.87 PRMT1 (0.52) PRMT1MAPTMEN1NPC1USP2
SCHEMBL7604383 0.87 PRMT1 (0.48) PRMT1MAPTMEN1NPC1USP2
SCHEMBL14269238 0.87 PRMT1 (0.47) PRMT1MAPTMEN1NPC1USP2
SCHEMBL13036858 0.87 PRMT1 (0.57) PRMT1MAPTMEN1NPC1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9069245-B2 Near-infrared absorptive layer-forming composition and multilayer film SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-06-30 US disclosed
US-8722307-B2 Near-infrared absorptive layer-forming composition and multilayer film comprising near-infrared absorptive layer INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2014-05-13 US disclosed
US-8323536-B2 Near-infrared absorbing dye, near-infrared absorptive film-forming composition, and near-infrared absorptive film SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-12-04 US disclosed
US-20120301828-A1 NEAR-INFRARED ABSORPTIVE LAYER-FORMING COMPOSITION AND MULTILAYER FILM COMPRISING NEAR-INFRARED ABSORPTIVE LAYER INTERNATIONAL BUSINESS MACHINES CORPORATION 2012-11-29 US disclosed
US-20120119171-A1 NEAR-INFRARED ABSORBING DYE, NEAR-INFRARED ABSORPTIVE FILM-FORMING COMPOSITION, AND NEAR-INFRARED ABSORPTIVE FILM SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-05-17 US disclosed
US-20110262862-A1 NEAR-INFRARED ABSORPTIVE LAYER-FORMING COMPOSITION AND MULTILAYER FILM SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-10-27 US disclosed
US-20110262863-A1 NEAR-INFRARED ABSORPTIVE LAYER-FORMING COMPOSITION AND MULTILAYER FILM INTERNATIONAL BUSINESS MACHINES CORPORATION 2011-10-27 US disclosed
EP-1473156-B1 Heat-sensitive lithographic printing plate precursor AGFA GRAPHICS NV (BE) 2008-02-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120119171-A1 NEAR-INFRARED ABSORBING DYE, NEAR-INFRARED ABSORPTIVE FILM-FORMING COMPOSITION, AND NEAR-INFRARED ABSORPTIVE FILM SLCO2A1, SLC39A3, SLCO2B1 PRMT1 652/4885MAPT 2202/4885MEN1 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.